Marex Group’s Abbott ABT Stock Holding History

Marex Group’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.37M	Buy	15,060 +6,459	+75%	+$590K	0.01%	444
2026 Q1	$883K	Buy	8,601 +6,349	+282%	+$717K	0.01%	468
2025 Q4	$282K	Buy	+2,252	New	+$287K	﹤0.01%	719

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Marex Group's ABT Position: Q2 2026 in Review

Marex Group increased its Abbott (ABT) stake by 75% in Q2 2026, buying an estimated $590K and bringing the position to 15,060 shares worth $1.37M. The position accounts for 0.01% of the portfolio, ranked #444.

Marex Group first reported a position in ABT in Q4 2025 and has held it in 3 quarters since. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Marex Group held 15,060 shares of Abbott worth $1.37M as of Q2 2026.
Marex Group bought 6,459 Abbott shares in Q2 2026, an estimated $590K.
Abbott made up 0.01% of Marex Group's portfolio in Q2 2026, its #444 holding.
Marex Group first reported a position in Abbott in Q4 2025 and has held it in 3 quarters since.
2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.